Sort
34,240 grants matching “atherosclerosis”
Molecular Biomedical Imaging Laboratory (NIBIB)
$400,000David Bluemke · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2017 · EB
Artery-on-a-chip with perivascular adipose tissue for pressure myography
$399,998Li-Hsin Han · Drexel University · · FY2019 · ENG
KLF2, monocyte activation and vascular inflammation
$399,968Mukesh Kumar Jain · Case Western Reserve University · R01 · FY2014 · HL
21/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
$399,940Elizabeth Mary Venditti · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · DK
Project 3: Remote control of hematopoiesis in cardiovascular disease
$399,938Filip K Swirski · Massachusetts General Hospital · P01 · FY2020 · HL
CORONARY ARTERY DYNAMIC GEOMETRY AND ATHEROSCLEROSIS
$399,909Duke University · R01 · FY2001 · HL
Scavenger Receptor BI in Cellular Cholesterol Metabolism
$399,896Erwin London · State University New York Stony Brook · R01 · FY2008 · HL
Project 3: Remote control of hematopoiesis in cardiovascular disease
$399,886Filip K Swirski · Massachusetts General Hospital · P01 · FY2021 · HL
Chemical Biology Studies of Human Disease-Relevant Small Molecules
$399,875Matthew D. Shair · Harvard University · R01 · FY2012 · GM
Project 3: Remote control of hematopoiesis in cardiovascular disease
$399,864Filip K Swirski · Massachusetts General Hospital · P01 · FY2019 · HL
Project 3: Remote control of hematopoiesis in cardiovascular disease
$399,846Filip K Swirski · Massachusetts General Hospital · P01 · FY2022 · HL
Project 3: Remote control of hematopoiesis in cardiovascular disease
$399,846Filip K Swirski · Massachusetts General Hospital · P01 · FY2023 · HL
The role of protease-activated receptor 2 in atherosclerosis
$399,792Albert Phillip Owens III · University Of Cincinnati · R01 · FY2018 · HL
Pharmacogenetics of the human prostacyclin receptor.
$399,750John Hwa · Dartmouth College · R01 · FY2009 · HL
Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiation
$399,750Kathleen Ann Martin · Dartmouth College · R01 · FY2008 · HL
Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiation
$399,750Kathleen Ann Martin · Dartmouth College · R01 · FY2009 · HL
Novel tools to maximize profiling of tissue and antigen specific immune dysregulation in allergy and inflammatory bowel disesase
$399,725Miriam Merad · Icahn School Of Medicine At Mount Sinai · U24 · FY2017 · AI
Novel tools to maximize profiling of tissue and antigen specific immune dysregulation in allergy and inflammatory bowel disesase
$399,725Miriam Merad · Icahn School Of Medicine At Mount Sinai · U24 · FY2015 · AI
Novel tools to maximize profiling of tissue and antigen specific immune dysregulation in allergy and inflammatory bowel disesase
$399,725Miriam Merad · Icahn School Of Medicine At Mount Sinai · U24 · FY2019 · AI
Novel tools to maximize profiling of tissue and antigen specific immune dysregulation in allergy and inflammatory bowel disesase
$399,725Miriam Merad · Icahn School Of Medicine At Mount Sinai · U24 · FY2016 · AI
Novel tools to maximize profiling of tissue and antigen specific immune dysregulation in allergy and inflammatory bowel disesase
$399,725Miriam Merad · Icahn School Of Medicine At Mount Sinai · U24 · FY2018 · AI
Anticardiolipin Antibodies and Oxidized Phospholipids
$399,722University Of California San Diego · R01 · FY2002 · HL
Metabolism of the VLDL receptor and ApoE receptor 2
$399,713Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2015 · HL
Longitudinal and quantitative MR plaque imaging for prediction of response to medical management in symptomatic intracranial atherosclerosis
$399,665Zhaoyang Fan · Cedars-Sinai Medical Center · R01 · FY2019 · HL
Angiogenesis in Diseased Model
$399,658Nilanjana Maulik · University Of Connecticut Sch Of Med/Dnt · R01 · FY2008 · HL